SA PRO
Free Account
Third Harmonic Bio, Inc.THRDNASDAQ
LOADING
|||
Switch Symbol:
OverviewChartsNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts are neutral — opinion is divided on direction.

Consensus Rating
Hold
5 analysts·Limited coverage
20%
Rating Distribution
Strong Buy
00%
Buy
120%
Hold
480%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Aug 9, 2024Morgan Stanley
Morgan Stanley Upgrades Third Harmonic Bio (THRD) to Overweight
Target:$20.00
+84.2%from $10.86
Jun 17, 2024Stifel Nicolaus
Stifel Starts Third Harmonic Bio (THRD) at Buy
Target:$23.00
+77.6%from $12.95
Jun 7, 2024Raymond James
Third Harmonic Bio initiated with an Outperform at Raymond James
Target:$18.00
+24.2%from $14.49
Dec 16, 2022Morgan Stanley
Morgan Stanley Downgrades Third Harmonic Bio to Equal-Weight, Lowers Price Target to $5
Target:$5.00
+17.1%from $4.27
Dec 16, 2022Jefferies
Jefferies Downgrades Third Harmonic Bio to Hold, Lowers Price Target to $3.6
Target:$3.60
-16.3%from $4.30

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance